Ambiq Micro's Third Quarter 2026 Financial Results - AMBIQ MICRO INC

Explicit Guidance:

• Q4 2026 Net Sales: Expected range of $43.5 million to $44.5 million, signaling the seventh consecutive quarter of sequential growth.
• Q4 2026 Operating Expenses: Non-GAAP OPEX expected between $25.5 million and $26.5 million; this includes $0.5 million in IP spending and variable costs associated with Atomic 110 and Apollo 340 tapeouts.
• Q4 2026 Non-GAAP Loss Per Share: Projected range of $0.09 to $0.03, based on a weighted average share count of 24.6 million.
• FY 2026 Net Sales: Full-year revenue guidance raised to approximately $140 million (vs. initial >$100 million expectation), nearly doubling FY2025 sales.
• FY 2026 Gross Margin: Expected to expand by approximately 300 basis points year-over-year, with Q4 margins expected to remain roughly flat at 3Q levels (48.7%).
• FY 2027 Outlook: Management expects "another year of strong growth" in 2027, driven by healthy volume and ASP increases, though specific financial ranges are reserved for the Q1 2027 earnings call.
• FY 2028 Outlook: Non-wearables revenue contribution expected to step up to low double digits of total revenue.

Business-Segment Outlook:

• Non-Wearables Diversification: Non-wearables revenue expected to represent mid-single-digit percentages of total revenue in 2026 and 2027, increasing to low double digits by 2028.
• New Product Launches: First customer devices based on Apollo 330 Plus and Apollo 510 Lite expected to reach the market in early 2027.
• Roadmap Milestones:
  • Apollo 340: Planned launch in 2026, with customer sampling expected in 2027; anticipated to accelerate expansion in medical, industrial, and smart building markets.
  • Atomic 110: On track for tape-out by year-end 2026, with customer sampling scheduled for Q1 2027.
  • Atomic 120: Will follow Atomic 110 architecture, extending the family to compute-intensive applications including vision.
• AI Software & Models: First customer deployment of an Ambic-developed AI model (voice-based use case) has commenced; management views this as a validation to broaden reach, particularly among customers lacking in-house AI resources.
• Emerging Verticals:
  • Infrastructure Monitoring: Design wins secured for AI-enabled glass break detection (security) and industrial asset performance/predictive maintenance (energy); these engagements expected to begin contributing to revenue in 2027.
  • Medical/Digital Health: Pipeline expanding across EEG, Parkinson's detection, blood glucose, heart, and ulcer monitors.

Market and Competitive Outlook:

• Demand Trends: Management anticipates a "fundamental shift toward greater edge AI adoption" with accelerating demand in Q4 2026 and through 2027.
• Product Mix: Growth driven by a shift toward more advanced solutions with higher Average Selling Prices (ASP), alongside volume increases.
• Competitive Positioning: Differentiation based on "ultra-low power compute" and "on-device AI" capabilities; capitalizing on a supply-constrained environment where competitors may struggle with lead times.
• Ecosystem Expansion: Leveraging reference designs, modules, and ecosystem partners to efficiently reach a broader customer base in infrastructure and industrial sectors.

Macro / Industry Outlook:

• Industry Shift: Belief in a "significant multi-year shift toward intelligence at the edge," driven by advances in model efficiency that reduce reliance on connectivity and cloud compute.
• Supply Chain Dynamics: While supply chain constraints (substrates, packaging, test) persist, management is confident in meeting demand within reasonable lead times, though "short lead time upside" remains an unfilled demand factor.
• Cost Pressures: Expectations of higher input and supply chain costs, though manufacturing efficiencies and product mix are expected to offset these pressures in Q4.

Strategic Initiatives:

• Capacity Expansion: Continued scaling of Apollo 3 and Apollo 5 families; expanding addressable opportunity via Apollo 340 launch.
• Partnerships:
  • Partnership with a leading global provider of cloud-based physical security solutions for AI-enabled sensors.
  • Partnership with an industrial AI company deploying predictive maintenance solutions for major U.S. energy operators.
• Vertical Diversification: Strategic pivot to capture mid-single-digit to low-double-digit revenue from non-wearables (industrial, medical, smart building) by 2028.
• Investment Focus: Continued investment in R&D to support multiple product development programs (Atomic 110, Apollo 340) and IP spending.

Risks and Headwinds to Outlook:

• Supply Chain Constraints: Unfilled demand due to extremely short lead times that partners cannot accommodate; reliance on "expedite requests" is not guaranteed.
• Input Cost Inflation: Higher input and supply chain costs could pressure margins if manufacturing efficiencies fail to offset.
• Execution Risk: Long design cycles in non-wearables markets mean revenue contribution will build gradually rather than immediately.
• Regulatory/Legal: Standard forward-looking statement disclaimer regarding risks that could cause actual results to differ materially from expectations (referenced in opening remarks).

Management Tone on the Future:

• Confidence Level: High confidence in the "scale and durability" of the edge AI opportunity and the company's ability to capture it.
• Growth Trajectory: Describes the current phase as the "early stages of a significant multi-year shift," expressing optimism for a "strong growth year" in 2027.
• Operational Readiness: Confidence in securing capacity despite a supply-constrained environment through strong supplier relationships and manufacturing efficiencies.
• Strategic Validation: Positive tone regarding the commercialization of in-house AI models as a "big moment" and validation of capabilities.

Miscellaneous:

• Customer Growth: Total active customer base grew approximately 50% year-over-year; 7 customers generated >$1M in sales (up from 3 a year ago).
• Geographic Exposure: Sales to end customers in China represented 17.3% of total net sales (vs. 6.7% prior year).
• Balance Sheet: Strong liquidity with $363.5 million in cash and cash equivalents and no debt.